UN warns US sanctions on Cuba cause spike in infant mortality and child cancer deaths due to lack of medical supplies, despite US claims humanitarian aid is exempt.
Glioblastoma, the aggressive stage 4 brain cancer, has a stubbornly low survival rate despite research. It's difficult to treat due to its diffusive nature, location, and resistance to chemotherapy. Average survival is 12-18 months, with only 5% surviving over 5 years.
A new analysis shows semaglutide (Ozempic/Wegovy) slows kidney disease progression in type 2 diabetes patients, improving kidney function and survival rates, even with a history of cardiovascular events. The drug mimics GLP-1 hormones and is also popular for weight loss.
Cancer claims 10 million lives annually, with varying deadliness. New drugs show promise for pancreatic and head/neck cancers, and precision medicine is advancing. However, a global shortfall of 100 million healthcare workers by 2050 and treatment delays are critical issues. Worryingly, cancer rates are rising in those under 50, linked to environmental factors.
An experimental drug, GRWD5769, has shown promise in early trials by shrinking tumors by at least 30% in six common cancer types. The drug works by preventing cancer cells from hiding from the immune system, making immunotherapy treatments more effective.
AstraZeneca's experimental breast cancer drug camizestrant faced a setback as a U.S. FDA advisory panel voted 6-3 against approval, citing concerns over the SERENA-6 trial design. The Phase 3 trial showed a 56% reduction in disease progression or death, but panel members weren't convinced early switching improved long-term survival. Shares fell 2% in morning trading, though analysts noted the drug's efficacy wasn't dismissed and the issue shouldn't impact AstraZeneca's $80 billion 2030 sales goal.
NHS struggling to cope with record numbers, which Cancer Research UK says puts progress on survival rates at riskThe number of people in the UK being diagnosed with cancer has reached a record high, with one person diagnosed every 80 seconds, a report reveals.Cancer Research UK found that more than 403,000 people were being diagnosed with the disease each year, largely due to a growing and ageing population, as people are more likely to develop cancer as they get older. Continue reading...
